NEW YORK: Global healthcare company Johnson & Johnson plans to start a phase 3 clinical trial of its Covid-19 vaccine ahead of its original schedule, possibly in late September, a senior company executive said. Johnson & Johnson is in talks with the US National Institute of Health to begin the …
Read More »Coronavirus Vaccine News: Johnson & Johnson Aims to Advance Late-Stage Covid-19 Vaccine Trial to September | World News
